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STUDIUM PRZYPADKU / CLINICAL VIGNETTE
Paravalvular aortic regurgitation as the reason 
for second CoreValve bioprosthesis implantation 
in a patient with native bicuspid valve
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CoreValve u pacjenta z natywną zastawką dwupłatkową
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We present the case of a 70-year-old male patient who was admitted to our centre with severe symptomatic aortic stenosis. His 
medical history included: hypertension, stroke (1998 and 2013) with subsequent left-sided paraparesis and status after traumatic 
upper right limb amputation in his youth. Patient’s logistic EuroSCORE was 18.1%, EuroSCORE II 5.7% and the Society of Thoracic 
Surgeons Score 2.7%. Transthoracic echocardiography showed impaired left ventricular ejection fraction of 27%, mean aortic pres-
sure gradient of 70.5 mm Hg, aortic valve area of 0.6 cm2, and peak velocity of 6.3 m/s. For precise aortic annulus measurement, 
transoesophageal echocardiography (TEE) and a computed tomography scan were performed and revealed a heavily calcified 
bicuspid valve with mean annulus diameter of 24 mm. Angiography demonstrated a significant lesion in the 3rd segment of right 
coronary artery (RCA). Due to the high operative risk, the patient was referred by the Heart Team for percutaneous coronary inter-
vention of RCA and transcatheter aortic valve implantation (TAVI) via the femoral route (considering the absence of atherosclerotic 
lesions in ilio-femoral arteries). Native valve was predilated with a 22 mm Numed balloon catheteter (Fig. 1A). On the basis of 
pre-procedural imaging, a 29 mm Medtronic CoreValve™ bioprosthesis was implanted at the annulus level. However, control 
angio and TEE showed low implantation accompanied by significant paravalvular aortic regurgitation (Fig. 1B). Haemodynamic 
measurement also confirmed a suboptimal effect with low diastolic aortic pressure (DAP) and high left-ventricular end-diastolic 
pressure (LVEDP) (Fig. 2A). Therefore, the  decision was made to implant a second bioprosthesis — another 29 mm CoreValve 
was placed and deployed 8–10 mm higher than the first one (Fig. 1C). Implantation of the second valve significantly decreased the 
magnitude of regurgitation from severe to no or mild, both in angiography and pressure recordings (Figs. 1D and 2A, respectively). 
It has been shown in several 
observational and randomised 
trials that even mild paraval-
vular regurgitation after TAVI 
is an independent predictor 
of long-term mortality. It is 
therefore of crucial importance 
to diagnose early and minimise 
the grade of regurgitation by 
post-dilatation or second valve 
deployment. This case demon-
strates that apart from imaging 
modalities, direct pressure 
measurement is an easy, reli-
able and reproducible method 
of paravalvular leak detection. 
Recently, it has been shown in 
a non-selected population of 
TAVI procedures that pressure 
gradient DDAP-LVEDP is a powerful 
predictor of mortality.
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Figure 1. A. Predilatation of native valve 
with 22 mm balloon catheter; B. Severe 
paravalvular regurgitation after 29 mm Core- 
Valve implantation (white arrow); C. Status 
post second 29 mm prosthesis placement, 
black arrow — distal edge of first CoreValve, 
white arrow — distal edge of second bio-
prosthesis; D. No-to-mild regurgitation  
after second CoreValve deployment
Figure 2. Invasive haemodynamics with 
simultaneous measurement of aortic and left 
ventricular pressures; A. Severe regurgita-
tion after first CoreValve placement with low 
pressure gradient DDAP-LVEDP; B. Significant 
improvement after implantation of second 
bioprosthesis reflected by DDAP-LVEDP increase
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